CAN AI CURE LIVER DISEASE?

What if the next breakthrough in liver disease comes from an algorithm rather than a lab bench? In this episode, Eliot sits down with Dr. Quin Wills, clinician, geneticist, and co-founder and CEO of Ochre Bio, an Oxford-based biotech using AI to tackle chronic liver disease.In this episode we unpack what AI actually is (and isn't), how it's being used to discover new medicines, and why liver disease is one of the biggest health challenges most people have never heard about.Along the way: why fatty liver used to be ignored by doctors, what large language models reveal about human intelligence, and whether AI could ever run a biotech on its own. CHAPTERS: 01:30 – Meet Quin Wills 03:30 – Why genetics led him to AI 04:32 – Liver disease: the myths 06:40 – The obesity wave 08:02 – A short history of AI 11:40 – AI and the scientific method 13:27 – How drugs get discovered 16:21 – AI from lab to clinic 19:29 – Better, cheaper, faster? 22:00 – Why humans still matter 24:46 – Biotech vs big pharma 28:01 – Could AI replace scientists? 30:15 – The chemistry comeback 33:03 – The next frontier: causality 36:15 – Failing forward in drug discovery 37:47 – Treating disease in combination 37:55 – What's next for Ochre Bio 39:06 – Closing thoughtsFOLLOW QUIN: LinkedIn: https://www.linkedin.com/in/quinwills/LEARN MORE ABOUT OCHRE BIO: LinkedIn: https://www.linkedin.com/company/ochre-bio/This podcast was produced by Crisis What Crisis Productions. www.crisiswhatcrisis.comWith special thanks to Mintz: life sciences lawyers who help turn scientific breakthroughs into reality. https://www.mintz.com